Our preceding research has unveiled that impeding the monoubiquitination process and the formation of nuclear foci of FANCD2 could heighten the susceptibility of non-small cell lung cancer (NSCLC) to cisplatin-induced DNA damage and apoptosis [27]. This evidence concerns the gene FANCD2 and non-small cell lung carcinoma.